Paul Rivard, Chief Legal Officer at MyMD Pharmaceuticals, Inc. (MYMD), bought 300,000 shares at $1.11 ($333K) on 2023-08-24, disclosed to the SEC on 2023-08-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.11 | 150,000 | $167K | 50.0% |
| 2 | $1.11 | 150,000 | $167K | 50.0% |
| Total | $1.11 avg | 300,000 | $333K | 100% |
| Filing → |
| MYMD | BUY | 2021-11-24 | $90K | — | Filing → |